Patient Guide: Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 252 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05855200
Status: 🟢 Enrolling Now
Condition: Neoplasms, Colonic Neoplasms
Phase: PHASE3

Where You Can Participate

This study is available at 252 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Los Angeles, California
  • • New Haven, Connecticut
  • • And 249 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer - Join Clinical Trial NCTNCT05855200

How to Join This Clinical Trial - NCTNCT05855200

Learn how to participate in this PHASE3 trial studying an investigational therapy for Neoplasms, Colonic Neoplasms. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Neoplasms, Colonic Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Neoplasms, Colonic Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05855200 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 252 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85715 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90027 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06520 - United States

Status: RECRUITING

Clinical Research Site

Washington, District of Columbia 20010 - United States

Status: WITHDRAWN

Clinical Research Site

Deerfield Beach, Florida 33064 - United States

Status: WITHDRAWN

Clinical Research Site

Fort Lauderdale, Florida 33316 - United States

Status: WITHDRAWN

Clinical Research Site

Marietta, Georgia 30060 - United States

Status: WITHDRAWN

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60612 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60637 - United States

Status: RECRUITING

And 242 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Neoplasms, Colonic Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships